Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS
· Delayed Price · Currency is USD
0.0377
+0.0017 (4.72%)
Apr 29, 2026, 11:00 AM EST
Oncotelic Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 0.09 | 0.09 | 0.17 | 0.24 | 0.57 | Upgrade
|
| Cash & Short-Term Investments | 0.09 | 0.09 | 0.17 | 0.24 | 0.57 | Upgrade
|
| Cash Growth | 3.17% | -49.46% | -29.43% | -57.55% | 19.99% | Upgrade
|
| Accounts Receivable | - | - | 0.02 | - | - | Upgrade
|
| Other Receivables | 0.05 | 0.02 | - | 0.02 | 0.02 | Upgrade
|
| Receivables | 0.05 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Prepaid Expenses | 1.04 | 0.01 | 0.06 | 0.02 | 0.02 | Upgrade
|
| Restricted Cash | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Total Current Assets | 1.2 | 0.13 | 0.27 | 0.3 | 0.63 | Upgrade
|
| Long-Term Investments | 388 | 22.65 | 22.65 | 22.64 | - | Upgrade
|
| Goodwill | 2.79 | 2.79 | 5.99 | 12.07 | 21.06 | Upgrade
|
| Other Intangible Assets | - | - | - | - | 0.82 | Upgrade
|
| Long-Term Deferred Charges | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | Upgrade
|
| Total Assets | 393.09 | 26.68 | 30.01 | 36.12 | 23.61 | Upgrade
|
| Accounts Payable | 1.64 | 1.69 | 1.66 | 1.74 | 1.93 | Upgrade
|
| Accrued Expenses | 1.28 | 1.09 | 1.12 | 1.11 | 1.57 | Upgrade
|
| Short-Term Debt | 12.25 | 13.09 | 10.68 | 11.26 | 8.99 | Upgrade
|
| Other Current Liabilities | 2.98 | 3.33 | 3.05 | 2.82 | 2.97 | Upgrade
|
| Total Current Liabilities | 18.14 | 19.2 | 16.5 | 16.92 | 15.45 | Upgrade
|
| Long-Term Debt | 1.66 | - | 1.9 | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 111.55 | - | - | - | - | Upgrade
|
| Total Liabilities | 131.36 | 19.2 | 18.4 | 16.92 | 15.45 | Upgrade
|
| Common Stock | 4.43 | 4.07 | 3.99 | 3.92 | 3.75 | Upgrade
|
| Additional Paid-In Capital | 47.1 | 42.22 | 41.66 | 41.42 | 35.22 | Upgrade
|
| Retained Earnings | 211.24 | -38.04 | -33.52 | -25.93 | -31.02 | Upgrade
|
| Total Common Equity | 262.76 | 8.25 | 12.13 | 19.41 | 7.96 | Upgrade
|
| Minority Interest | -1.03 | -0.77 | -0.52 | -0.22 | 0.2 | Upgrade
|
| Shareholders' Equity | 261.73 | 7.48 | 11.61 | 19.19 | 8.16 | Upgrade
|
| Total Liabilities & Equity | 393.09 | 26.68 | 30.01 | 36.12 | 23.61 | Upgrade
|
| Total Debt | 13.91 | 13.09 | 12.57 | 11.26 | 8.99 | Upgrade
|
| Net Cash (Debt) | -13.82 | -13 | -12.4 | -11.02 | -8.42 | Upgrade
|
| Net Cash Per Share | -0.03 | -0.03 | -0.03 | -0.02 | -0.03 | Upgrade
|
| Filing Date Shares Outstanding | 444.2 | 408.29 | 399.68 | 392.87 | 378.63 | Upgrade
|
| Total Common Shares Outstanding | 442.6 | 407.29 | 399.18 | 391.85 | 375.29 | Upgrade
|
| Working Capital | -16.95 | -19.07 | -16.23 | -16.62 | -14.83 | Upgrade
|
| Book Value Per Share | 0.59 | 0.02 | 0.03 | 0.05 | 0.02 | Upgrade
|
| Tangible Book Value | 259.97 | 5.46 | 6.14 | 7.34 | -13.93 | Upgrade
|
| Tangible Book Value Per Share | 0.59 | 0.01 | 0.02 | 0.02 | -0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.